Mammalian sex determination: From gonads to brain

Molecular Genetics and Metabolism

Volumn 65, Issue 2, 1998, Pages 74-84

  Vilain, Eric ^a   McCabe, Edward R B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DAX1; DMT1; Dosage sensitive sex reversal (DSS); Gonadal development; Hypothalamic pituitary adrenal gonadal axis; Mullerian inhibiting substance; Sex determination; SOX9; SRY; Steroidogenic Factor 1 (SF1); Testis determining factor (TDF); WT1

Indexed keywords

DNA; HIGH MOBILITY GROUP PROTEIN; SEX HORMONE;

BRAIN; FEMALE; GONAD DEVELOPMENT; HUMAN; MALE; MAMMAL; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; REVIEW; SEX DETERMINATION; SEX TRANSFORMATION; SEXUAL DEVELOPMENT; TRANSGENE; TRANSGENIC MOUSE; X CHROMOSOME; Y CHROMOSOME;

EID: 0032191858     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1998.2749     Document Type: Article

References (76)

1. 1. Jost A. Recherches sur la différenciation sexuelle de l'embryon de lapin. III. Rôle des gonades fœtales dans la différenciation sexuelle somatique. Arch Anat Microsc Morphol Exp 36:271-315, 1947.
2. 2. Jost A, Perchellet JP, Prépin J, Vigier B. The prenatal development of bovine freemartins. In Symposium on Intersexuality (Reinborn R, Ed.). Berlin: Springer-Verlag, pp 392-406, 1975.
3. 3. Ford CE, Jones KW, Polani PE, de Almeida JC, Brigg JH. A sex chromosome anomaly in a case of gonadal dysgenesis (Turner syndrome). Lancet i:711-713, 1959.
4. 4. Jacobs PA, Strong JA. A case of human intersexuality having a possible XXY sex-determining mechanism. Nature 183: 302-303, 1959.
5. 5. Sinclair AH, Berta P, Palmer MS, Hawkin JR, Griffiths BL, Smith MJ, Foster JM, Frischauf AM, Lovell-Badge R, Goodfellow PN. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA binding motif. Nature 346:240-244, 1990.
6. 6. Ferguson-Smith MA. X-Y chromosomal interchange in the aetiology of true hermaphroditism and of XX Klinefelter's syndrome. Lancet ii:475-476, 1966.
7. 7. Palmer MS, Sinclair AH, Berta P, Ellis NA, Goodfellow PN, Abbas NE, Fellous M. Genetic evidence that ZFY is not the testis-determining factor. Nature 342:937-939, 1989.
8. 8. Harley VR, Jackson DI, Hextall PJ, Hawkins JR, Berkovitz GD, Sockanathan S, Lovell-Badge R, Goodfellow PN. DNA binding activity of recombinant SRY from normal males and XY females. Science 255:453-455, 1992.
9. 9. Koopman P, Munserberg A, Capel B, Vivian N, Lovell-Badge R. Expression of a candidate sex-determining gene during mouse testis differentiation. Nature 348:450-452, 1990.
10. 10. Berta P, Hawkins JR, Sinclair AH, Taylor A, Griffiths B, Goodfellow PN, Fellous M. Genetic evidence equating SRY and the testis-determining factor. Nature 348:448-450, 1990.
11. 11. Hawkins JR, Taylor A, Berta P, Levilliers J, Van der Auwera B, Goodfellow PN. Mutational analysis of SRY: Nonsense and missense mutations in XY sex reversal. Hum Genet 88:471-474, 1992.
12. 12. Hawkins JR, Taylor A, Goodfellow PN, Migeon CJ, Smith KD, Berkovitz GD. Evidence for increased prevalence of SRY mutations in XY females with complete rather than partial gonadal dysgenesis. Am J Hum Genet 51:979-984, 1992.
13. 13. Jäger RJ, Anvret M, Hall K, Scherer G. A human XY female with frame shift mutation in the candidate sex determining gene, SRY. Nature 348:452-454, 1990.
14. 14. McElreavey K, Vilain E, Abbas N, Costa J-M, Souleyreau N, Kucheria K, Boucekkine C, Thibault E, Flamant F, Fellous M. XY sex-reversal associated with a deletion 5′ to the SRY HMG-box in the testis-determining-region. Proc Natl Acad Sci USA 89:11016-11020, 1992.
15. 15. McElreavey K, Vilain E, Boucekkine C, Vidaud M, Jaubert F, Richaud F, Fellous M. XY sex reversal associated with a nonsense mutation in SRY. Genomics 13:838-840, 1992.
16. 16. Müller J, Schwartz M, Skakkebaek NE. Analysis of the sex determining region of the Y chromosome (SRY) in sex reversed patients: Point mutation in SRY causing sex reversion in a 46, XY female. J Clin Endocrinol Metabol 75:331-333, 1992.
17. 17. Affara NA, Chalmers IJ, Ferguson-Smith MA. Analysis of the SRY gene in 22 sex-reversed XY females identifies four new point mutations in the conserved DNA binding domain. Hum Mol Genet 2:785-789, 1993.
18. 18. Zeng YT, Ren ZR, Zhang ML, Huang Y, Zeng FY, Huang SZ. A new de novo mutation (A113T) in HMG box of the SRY gene leads to XY gonadal dysgenesis. J Med Genet 30:655-657, 1993.
19. 19. Poulat F, Soullier S, Goze C, Heitz F, Calas B, Berta P. Description and functional implications of a novel mutation in the sex-determining gene SRY. Hum Mutat 3:200-204, 1994.
20. 20. Tajima J, Nakae J, Shinohara N, Fujieda K. A novel mutation localized in the 3′ non-HMG box region of the SRY gene in 46, XY gonadal dysgenesis. Hum Mol Genet 3:1187-1189, 1994.
21. 21. Brown S, Yu C, Lanzano P, Heller D, Thomas L, Warburton D, Kitajewski J, Stadtmauer L. A de novo mutation (Gln2Stop) at the 5′ end of the SRY gene leads to sex reversal with partial ovarian function. Am J Hum Genet 62:189-912, 1998.
22. 22. Koopman P, Gubbay J, Vivian N, Goodfellow PN, Lovell-Badge R. Male development of chromosomally female mice transgenic for Sry. Nature 351:117-121, 1991.
23. 23. Ner S. HMGs everywhere. Curr Biol 2:208-210, 1992.
24. 24. Giese K, Pagel J, Grosschedl R. Distinct DNA-binding properties of the high mobility group domain of murine and human SRY sex-determining factors. Proc Natl Acad Sci USA 91:3368-3372, 1994.
25. 25. Harley V, Lovell-Badge R, Goodfellow PN. Definition of a consensus DNA binding site for SRY. Nucleic Acids Res 22:1500-1501, 1994.
26. 26. Poulat F, De Santa Barbara P, Desclozeaux M, Soullier S, Moniot B, Bonneaud N, Boizet B, Berta P. The human testis determining factor SRY binds a nuclear factor containing PDZ protein interaction domains. J Biol Chem 272:7167-7172, 1997.
27. 27. Vilain E, McElreavey KD, Jaubert F, Raymond J-P, Richaud F, Fellous M. Familial case with sequence variant in the testis-determining region associated with two sex phenotypes. Am J Hum Genet 50:1008-1011, 1992.
28. 28. Jäger R, Harley VR, Pfeiffer RA, Goodfellow PN, Scherer G. A familial mutation in the testis-determining gene SRY shared by both sexes. Hum Genet 90:350-355, 1992.
29. 29. Domenice S, Yumie Nishi M, Correia Billerbeck AE, Latronico AC, Aparecida Medeiros M, Russell AJ, Vass K, Marino Carvalho F, Costa Frade EM, Prado Arnhold IJ, Bilharinho Mendonca B. A novel missense mutation (S18N) in the 5′ non-HMG box region of the SRY gene in a patient with partial gonadal dysgenesis and his normal male relatives. Hum Genet 102:213-215, 1998.
30. 30. Pontiggia A, Rimini R, Harley VR, Goodfellow PN, Lovell-Badge R, Bianchi ME. Sex-reversing mutations affect the architecture of SRY-DNA complexes. EMBO J 13:6115-6124, 1994.
31. 31. Dubin RA, Ostrer H. Sry is a transcriptional activator. Mol Endocrinol 8:1182-1192, 1994.
32. 32. McElreavey K, Barbaux S, Ion A, Fellous M. The genetic basis of murine and human sex determination: A review. Heredity 75:599-611, 1995.
33. 33. Vilain E, Lefiblec B, Morichon-Delvallez N, Brauner R, Dommergues M, Dumez Y, Jaubert F, Boucekkine C, McElreavey K, Vekemans M, Fellous M. SRY-negative XX fetus with complete male phenotype. Lancet 343:240-241, 1994.
34. 34. Arn P, Chen H, Tuck-Muller CM, Mankinen C, Wachtel G, Li S, Shen CC, Wachtel SS. SRVX, a sex reversing locus in Xp21.2-p22.11. Hum Genet 93:389-393, 1994.
35. 35. Bardoni B, Zanaria F, Guioli S, Floridia G, Worley KC, Tonini G, Ferrante E, Chiumello G, McCabe ERB, Fraccaro M, Zuffardi O, Camerino G. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nature Genet 7:497-501, 1994.
36. 36. Zanaria E, Muscatelli F, Bardoni B, Strom TM, Guioli S, Guo W, Lalli E, Moser C, Walker AP, McCabe ERB, Meitinger T, Monaco AP, Sassone-Corsi P, Camerino G. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372:635-641, 1994.
37. 37. Guo W, Burris TP, McCabe ERB. Expression of DAX-1, the gene responsible for X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism, in the hypothalamic-pituitary-adrenal/gonadal axis. Biochem Mol Med 56:8-13, 1995.
38. 38. Seol W, Choi HS, Moore DD. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272:1336-1339, 1996.
39. 39. Zazopoulos E, Lalli E, Stocco DM, Sassone-Corsi P. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 390:311-315, 1997.
40. 40. Burris TP, Guo W, McCabe ERB. The gene responsible for adrenal hypoplasia congenita, DAX-1, encodes a nuclear hormone receptor that defines a new class within the superfamily. Rec Prog Horm Res 51:241-259, discussion, 259-260, 1996.
41. 41. Swain A, Zanaria E, Hacker A, Lovell-Badge R, Camerino G. Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nature Genet 12:404-409, 1996.
42. 42. Ikeda Y, Swain A, Weber TJ, Hentges KE, Zanaria E, Lalli E, Tamai KT, Sassone-Corsi P, Lovell-Badge R, Camerino G, Parker KL. Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development. Mol Endocrinol 10:1261-1272, 1996.
43. 43. Habiby RL, Boepple P, Nachtigall L, Sluss PM, Crowley WF Jr, Jameson JL. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production. J Clin Invest 98:1055-1062, 1997.
44. 44. Fujieda K, Nakae J, Abe S, Shinohara N, Murashita M, Sato K. Analysis of hypothalamic-pituitary-testicular axis in a patient with X-linked adrenal hypoplasia congenita. Abstract. Endocrine Society Meeting, June 1998, New Orleans.
45. 45. Swain A, Narvaez V, Burgoyne P, Camerino G, Lovell-Badge R. Dax1 antagonizes Sry action in mammalian sex determination. Nature 391:761-767, 1998.
46. 46. Whitfield LS, Lovell-Badge R, Goodfellow PN. Rapid sequence evolution of the mammalian sex-determining gene SRY. Nature 364:713-715, 1993.
47. 47. Vilain E, McElreavey K, Herskowitz I, Fellous M. La détermination du sexe: Faits et nouveaux concepts. Med Sci 8:I-VII, 1992.
48. 48. McElreavey K, Vilain E, Abbas N, Herskowitz I, Fellous M. A regulatory cascade hypothesis for mammalian sex determination: SRY represses a negative regulator of male development. Proc Natl Acad Sci USA 90:3368-3372, 1993.
49. 49. Ferguson-Smith MA. Abnormalities of human sex determination. J Inherit Metab Dis 15:518-525, 1992.
50. 50. Pelletier J, Bruening W, Li FP, Glaser T, Haber DA, Housman D. WT1 mutations contribute to abnormal genital system development and hereditary Wilm's tumor. Nature 353: 431-434, 1991.
51. 51. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R. WT-1 is required for early kidney development. Cell 74:679-691, 1993.
52. 52. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-447, 1991.
53. 53. Bardeesy N, Zabel B, Schmitt K, Pelletier J. WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion. Genomics 21:663-664, 1994.
54. 54. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F, Fekete CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nature Genet 17:467-470, 1997.
55. 55. Morohashi K, Honda S, Inomata Y, Handa H, Omura T. A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. J Biol Chem 267:17913-17919, 1992.
56. 56. Ikeda Y, Shen W-H, Ingraham HA, Parker KL. Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol Endocrinol 8:654-662, 1994.
57. 57. Luo X, Ikeda Y, Parker KL. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77:481-490, 1994.
58. 58. Burris TP, Guo W, Le T, McCabe ERB. Identification of a putative steroidogenic factor-1 response element in the DAX-1 promoter. Biochem Biophys Res Commun 214:576-581, 1995.
59. 59. Guo W, Burris TP, Zhang YH, Huang BL, Mason J, Copeland KC, Kupfer SR, Pagon RA, McCabe ERB. Genomic sequence of the DAX1 gene: An orphan nuclear receptor responsible for X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. J Clin Endocrinol Metab 81:2481-2486, 1996.
60. 60. Vilain E, Guo W, Zhang YH, McCabe ERB. DAX1 gene expression upregulated by steroidogenic factor 1 in an adrenocortical carcinoma cell line. Biochem Mol Med 61:1-8, 1997.
61. 61. Ito M, Yu R, Jameson JL. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol 17: 1476-1483, 1997.
62. 62. Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flanagan JN, Hammer GD, Ingraham HA. Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 93:445-454, 1998.
63. 63. Shen W-H, Moore CCD, Ikeda Y, Parker KL, Ingraham HA. Nuclear receptor steroidogenic factor 1 regulates the Müllerian inhibiting substance gene: A link to the sex determination cascade. Cell 77:651-661, 1994.
64. 64. Foster JW, Dominguez-Steglich MA, Guili S, Kowk G, Weller PA, Stefanovic M, Weissenbach J, Mansour S, Young ID, Goodfellow PN. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525-529, 1994.
65. 65. Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Bricarelli FD, Keutel J, Hustert E, Wolf U, Tommerup N, Schempp W, Sherer G. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79:1111-1120, 1994.
66. 66. Houston CS, Opitz JM, Spranger JW, Macpherson RI, Reed MH, Gilbert EF, Herrmann J, Schinzel A. The campomelic syndrome: Review, report of 17 cases, and follow-up on the currently 17-year-old boy first reported by Maroteaux et al in 1971. Am J Med Genet 15:3-28, 1983.
67. 67. Bennett CP, Docherty Z, Robb SA, Ramani P, Hawkins JR, Grant D. Deletion 9p and sex reversal. J Med Genet 30:518-520, 1993.
68. 68. McDonald MT, Flejter W, Sheldon S, Putzi MJ, Gorski JL. XY sex reversal and gonadal dysgenesis due to 9p24 monosomy. Am J Med Genet 73:321-326, 1997.
69. 69. Veitia R, Nunes M, Brauner R, Doco-Fenzy M, Joanny-Flinois O, Jaubert F, Lortat-Jacob S, Fellous M, McElreavey K. Deletions of distal 9p associated with 46,XY male to female sex reversal: definition of the breakpoints at 9p23.3-p24.1. Genomics 41:271-274, 1997.
70. 70. Raymond CS, Shamu CE, Shen MM, Seifert KJ, Hirsch B, Hodgkin J, Zarkower D. Evidence for evolutionary conservation of sex-determining genes. Nature 391:691-695, 1998.
71. 71. Wilkie AO, Campbell FM, Daubeney P, Grant DB, Daniels RJ, Mullarkey M, Affara NA, Fitchett M, Huson SM. Complete and partial XY sex reversal associated with terminal deletion of 10q: report of 2 cases and literature review. Am J Med Genet 46:597-600, 1993.
72. 72. Chung YP, Hwa HL, Tseng LH, Shyu MK, Lee CN, Shih JC, Hsieh FJ. Prenatal diagnosis of monosomy 10q25 associated with single umbilical artery and sex reversal: report of a case. Prenatal Diagnosis 18:73-77, 1998.
73. 73. Barnhart KM, Mellon PL. The orphan nuclear receptor, steroidogenic factor-1, regulates the glycoprotein hormone alpha-subunit gene in pituitary gonadotropes. Mol Endocrinol 8:878-885, 1994.
74. 74. Keri RA, Nilson JH. A steroidogenic factor-1 binding site is required for activity of the luteinizing hormone beta subunit promoter in gonadotropes of transgenic mice. J Biol Chem 271:10782-10785, 1996.
75. 75. Zannini M, Avantaggiato V, Biffali E, Arnone MI, Sato K, Pischetola M, Taylor BA, Phillips SJ, Simeone A, Di Lauro R. TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J 16:3185-3197, 1997.
76. 76. Vilain E, Nihoul-Fekete C. Genetique du determinisme et de la differenciation sexuelle. In Progres en Pediatrie: Genetique (Lyonnet S, Munnich A, Eds.). Paris: Doin, pp 203-218, 1997.